The president and chief executive of the California Institute for Regenerative Medicine C Randal Mills is to step down at the end of June.
CIRM was created in 2004 by California voters in response to federal policies banning some stem cell research. Its $3-billion budget is expected to last until 2020. That’s thanks in part to the work of Mills, who helped reshape CIRM’s strategy for spending its last $900 million.
Mills has announced that he will leave at the end of June to become president and chief executive of the National Marrow Donor Program and Be The Match, which help to arrange bone marrow and umbilical cord blood donations. Maria Millan, CIRM’s vice-president for therapeutics, will take over from Mills while the board considers its options, according to a press release.
This article is only available to Research Professional News subscribers or Pivot-RP users.
If you are a Research Professional News subscriber you can log in and view the article via this link
Pivot-RP users can log in and view the article via this link.